SA Medicine
SA Medicine 84号(2013年04月号) 連載「飼い主と獣医師のためのインフォームドコンセントガイド8」
©2000-2020 EDUWARD Press Publishing Co., Ltd.
SCROLL
■『猫の肥大型心筋症』髙島一昭先生 著
1.Richardson P, McKenna W, Bristow M, et al. Report of the1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies. Circulation, 93: 841-842.(1996)
2. Riesen SC, Kovacevic A, Lombard CW, Amberger C: Prevalence of heart disease in symptomatic cats: an overview from 1998 to 2005. Schweiz Arch Tierheilkd,149,65-71(2007)
3. Ferasin L, Sturgess CP, Cannon MJ, et al: Feline idiopathic cardiomyopathy: a retrospective study of 106 cats (1994-2001). J Feline Med Surg, 151-159(2003)
4. MacDonald K: Mycocardial disease Feline. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine 7th ed., 1328-1341, Saunders, St. Louis (2010)
5. Cote E, MacDonald KA, Meurs KM, Sleeper MM: Cardiomyopathies, Feline cardiology, John Wiley & Sons,Inc, West Sussex(2011)
6. Maron BJ , Towbin JA, Thiene G, et al . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the
Council on Clinical Cardiology, Heart Failure and Transplantation Committee. Circulation,113,1807-1816.(2006)
7. Elliott P, Andersson B, Arbustini E, et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29,270-276(2008)
8. Meurs KM, Sanchez X, David RM, et al: A cardiac myosin binding protein C mutation in the Maine Coon cat with familial hypertrophic cardiomyopathy. Hum Mol Genet. 1,14, 3587-3593( 2005)
9. Mary J, Chetboul V, Sampedrano CC, Abitbol M, et al: Prevalence of the MYBPC3-A31P mutation in a large European feline population and association with hypertrophic cardiomyopathy in the Maine Coon breed. J Vet Cardiol. ,12, 155-161(2010)
10.Johns SM, Nelson OL, Gay JM: Left atrial function in cats with left-sided cardiac disease and pleural effusion or pulmonary edema. J Vet Intern Med. ,26,1134-1139(2012)
11. Rush JE, Freeman LM, Fenollosa NK, Brown DJ: Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999). J Am Vet Med Assoc. 15,220,202-207(2002 )
12.Boon JA ed: Veterinary echocardiography 2nd ed., John Wiley & Sons,Inc, West Sussex(2011)
13.Taillefer M, Di Fruscia R.: Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study. Can Vet J. ,47,437-45(2006)
14. MacDonald KA, Kittleson MD, Larson RF, Kass P: The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. J Vet Intern Med. ,20,1093-105(2006)
15. Amberger CN, Glardon O, Glaus T, Hörauf A,et al: Effects of benazepril in the treatment of feline hypertrophic cardiomyopathy Results of a prospective, open-label, multicenter clinical trial. J Vet Cardiol.1,19-26(1999)
16.MacDonald KA, Kittleson MD, Larson RF, Kass P, et al: The effect of ramipril on left ventricular mass, myocardial fibrosis, diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure. J Vet Intern Med. 20,1093-1105(2006)
17.Rush JE, Freeman LM, Brown DJ, Smith FW Jr.: The use of enalapril in the treatment of feline hypertrophic cardiomyopathy. J Am Anim Hosp Assoc. 34,38-41(1998)
18. Bright JM, Golden AL, Gompf RE, Walker MA, Toal RL: Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy. J Vet Intern Med. 5,272-82(1991)
19. Bright JM, Golden AL.: Evidence for or against the efficacy of calcium channel blockers for management of hypertrophic cardiomyopathy in cats. Vet Clin North Am Small Anim Pract. ,21,1023-1034.(1991)
19. Gordon SG, Saunders AB, Roland RM, Winter RL: Effect of oral administration of pimobendan in cats with heart failure. J Am Vet Med Assoc. 1,241,89-94(2012)
20. Macgregor JM, Rush JE, Laste NJ, Malakoff RL: Use of pimobendan in 170 cats (2006-2010). J Vet Cardiol.,13,251-60(2011)
21. Atkins CE, Gallo AM, Kurzman ID, Cowen P: Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc. 15,201,613-618(1992)